INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Cash Flow from Investing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹4.28 Cr | ₹-6.67 Cr | ₹-5.40 Cr | ₹-1.75 Cr | ₹-0.57 Cr |
What is the latest Cash Flow from Investing Activities ratio of INDO US BIOTECH ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹4.28 Cr |
Mar2023 | ₹-6.67 Cr |
Mar2022 | ₹-5.40 Cr |
Mar2021 | ₹-1.75 Cr |
Mar2020 | ₹-0.57 Cr |
How is Cash Flow from Investing Activities of INDO US BIOTECH Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹4.28 Cr | Positive | |
Mar2023 | ₹-6.67 Cr | Negative | |
Mar2022 | ₹-5.40 Cr | Negative | |
Mar2021 | ₹-1.75 Cr | Negative | |
Mar2020 | ₹-0.57 Cr | - |
Compare Cash Flow from Investing Activities of peers of INDO US BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDO US BIOTECH | ₹293.0 Cr | -2.4% | -14% | -45.6% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,807.7 Cr | 1.9% | -3.5% | -26.6% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,094.5 Cr | 2.5% | 9.1% | 11.9% | Stock Analytics | |
VENKYS (INDIA) | ₹2,133.3 Cr | 2.7% | 0.7% | -36% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,483.9 Cr | -2.9% | 4.4% | -27.4% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹513.5 Cr | -3.1% | -9.8% | NA | Stock Analytics |
INDO US BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | -2.4% |
-14% |
-45.6% |
SENSEX | -0.3% |
-0.8% |
-1.9% |
You may also like the below Video Courses